Comparison of Azathioprine, Cyclophosphamide, and Gold in Treatment of Rheumatoid Arthritis

Currey, H. L. F.; Harris, J.; Mason, R. M.; Woodland, J.; Beveridge, T.; Roberts, C. J.; Vere, D. W.; Dixon, A. St. J.; Davies, J.; Owen-Smith, B.
September 1974
British Medical Journal;9/28/1974, Vol. 3 Issue 5934, p763
Academic Journal
No abstract available.


Related Articles

  • Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. Berry, H.; Lilyanage, S.P.; Barnes, R.A.; Berger, L.A.; Evans, S. // British Medical Journal;5/1/1976, Vol. 1 Issue 6017, p1052 

    Focuses on the use of azathioprine and penicillamine for the treatment of rheumatoid arthritis in London, England. Comparison on the efficacy and toxicity between azathioprine and penicillamine; Side effects of penicillamine drug; Effectivity of the drugs.

  • NEW PRODUCTS.  // Drug Topics;3/22/2004, Vol. 148 Issue 6, p98 

    Reports on Salix Pharmaceuticals Ltd.'s launching of the immunosupressive agent Azasan (azathioprine) for the treatment of rheumatoid arthritis and related diseases.

  • Treatment of severe rheumatoid arthritis . Wright, Verna // British Medical Journal (Clinical Research Edition);2/15/1986, Vol. 292 Issue 6518, p431 

    Examines the treatment of severe rheumatoid arthritis. Symptoms of the disease; Development of steroid osteoporosis with crush fractures; Description of azathioprine.

  • Oral gold for rheumatoid arthritis. Wright, V. // British Medical Journal (Clinical Research Edition);10/6/1984, Vol. 289 Issue 6449, p858 

    Focuses on the efficacy of oral gold in the form of Auranofin for the treatment of rheumatoid arthritis. Toxicity of the oral gold; Benefits and drawbacks of the treatment; Comparison on the beneficial effects between oral gold and hydroxychloroquine.

  • New Hope When Old Drugs Fail. KG; Harrar, Sari; Caruso, David; Foley, Denise; Gault, Kevin; Kiser, Sherry; Matus, Jordan; Riddle, Judith Springer; Tennesen, Michael // Prevention;Dec2002, Vol. 54 Issue 12, p157 

    Discusses the use of cyclophosphamide chemotherapy as treatment for rheumatoid arthritis. How the cancer drug shocks the immune system.

  • A clinical and economic review of disease-modifying antirheumatic drugs. Gabriel, S.E.; Coyle, D.; Moreland, L.W. // PharmacoEconomics;Jul2001, Vol. 19 Issue 7, p715 

    Rheumatoid arthritis is one of the most common chronic systemic inflammatory diseases, affecting approximately 1% of the adult population. Disease-modifying antirheumatic drugs (DMARDs) have been the mainstay of treatment for rheumatoid arthritis when combined with physical therapy and aspirin...

  • Azathioprine.  // Reactions Weekly;8/20/2011, Issue 1365, p9 

    The article describes the case of a 49-year-old woman with rheumatoid arthritis and acquired haemophilia who developed myelosuppression while receiving treatment with azathioprine.

  • Azathioprine-induced shock. Cunningham, T.; Barraclough, D.; Muirden, K. // British Medical Journal (Clinical Research Edition);9/26/1981, Vol. 283 Issue 6295, p823 

    Examines the acute hypersensitivity reactions caused by azathioprine in patients with rheumatoid arthritis. Side-effects of the drug; Use of antihistamines for treatment; Detection of gastroenteritis.

  • Vasculitis and the dental team. Mills, John // Vital (17417503);Fall2013, Vol. 10 Issue 4, p29 

    The article discusses auto-immune disease primary systemic vasculitis (PSV). It informs about anti-neutrophil cytoplasmic antibody associated with vasculitis including Wegener's Granulomatosis, Microscopic Polyangiitis, and Churg Strauss syndrome. It states that immune-suppressing drugs such as...

  • Antineoplastics/immunosuppressants.  // Reactions Weekly;1/9/2010 Part 1 of 2, Issue 1283, p15 

    The article describes the clinical cases of four elderly patients who developed primary central nervous system (CNS) lymphoma and malignant melanoma while under a treatment regiment composed of azathioprine, mycophenolate mofetil, prednisone, methotrexate, cyclophosphamide and/or rituximab. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics